• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Stille

247.00 SEK

-0.80 %

Less than 1K followers

STIL

First North Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
-0.80 %
-0.80 %
+25.38 %
+26.02 %
+18.75 %
+21.67 %
+131.92 %
+112.93 %
+138.29 %

Stille develops, manufactures and markets medical devices for specialist surgeons. Priority areas are surgical instruments and special tables for cardiovascular surgery, gynecology and urology. The company's products are used by users on a global level. In addition to its core business, it also offers instrument care training. Stille was originally founded in 1841 and has its headquarters in Eskilstuna.

Read more
Market cap
2.22B SEK
Turnover
213.65K SEK
Revenue
567.63M
EBIT %
12.9 %
P/E
39.84
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
23/7
2026

Interim report Q2'26

23/10
2026

Interim report Q3'26

All
Press releases
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Regulatory press release5/7/2026, 4:00 PM

Kommuniké från Stilles årsstämma 2026

Stille
Regulatory press release5/7/2026, 4:00 PM

Report from Stille’s annual general meeting 2026

Stille
Press release4/28/2026, 3:28 PM

Redeye: Stille (Q1 Review): Starting 2026 in style with momentum expected to continue

Stille

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release4/24/2026, 6:00 AM

Stille AB (publ) redovisar idag rapporten för det första kvartalet 2026.

Stille
Regulatory press release4/24/2026, 6:00 AM

Stille AB (publ) today presents the report for the first quarter 2026.

Stille
Press release4/17/2026, 1:45 PM

Inbjudan: Presentation av Stilles delårsrapport för Q1 2026.

Stille
Press release4/17/2026, 1:45 PM

Invitation: Presentation of Stille’s interim report for Q1 2026.

Stille
Regulatory press release4/2/2026, 7:00 AM

KALLELSE TILL ÅRSSTÄMMA I STILLE AB

Stille
Regulatory press release4/2/2026, 7:00 AM

NOTICE OF ANNUAL GENERAL MEETING OF STILLE AB

Stille
Regulatory press release4/2/2026, 6:00 AM

Stille AB: Annual Report 2025

Stille
Regulatory press release4/2/2026, 6:00 AM

Stille AB: Årsredovisning 2025

Stille
Press release2/13/2026, 12:04 PM

Redeye: Stille: (Q4 review): Easing headwinds and solid outlook at 11x current year EV/EBITDA

Stille
Regulatory press release2/12/2026, 7:00 AM

Stille AB (publ) today presents the report for the fourth quarter and full year 2025.

Stille
Regulatory press release2/12/2026, 7:00 AM

Stille AB (publ) redovisar idag rapporten för det fjärde kvartalet och helåret 2025.

Stille
Regulatory press release12/23/2025, 1:40 PM

Rättelse: Valberedning för årsstämman 2026 i Stille

Stille
Regulatory press release12/23/2025, 1:40 PM

Correction: Nominating Committee for the Annual General Meeting 2026 in Stille

Stille
Regulatory press release12/23/2025, 1:00 PM

Valberedning för årsstämmman 2026 i Stille

Stille
Regulatory press release12/23/2025, 1:00 PM

Nominating Committee for the Annual General Meeting 2026 in Stille

Stille
Press release10/27/2025, 1:31 PM

Redeye: Stille (Q3 update) - Prolonged headwind but valuation remains undemanding

Stille
Regulatory press release10/23/2025, 6:00 AM

Stille AB (publ) redovisar idag rapporten för det tredje kvartalet 2025.

Stille